APA

Corazao-Rozas P., Guerreschi P., André F., Gabert P., Lancel S., Dekiouk S., Fontaine D., Tardivel M., Savina A., Quesnel B., Mortier L., Marchetti P. & Kluza J. (20180111). Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors. : Oncotarget.

Chicago

Corazao-Rozas Paola, Guerreschi Pierre, André Fanny, Gabert Pierre-Elliott, Lancel Steve, Dekiouk Salim, Fontaine Delphine, Tardivel Meryem, Savina Ariel, Quesnel Bruno, Mortier Laurent, Marchetti Philippe and Kluza Jérome. 20180111. Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors. : Oncotarget.

Harvard

Corazao-Rozas P., Guerreschi P., André F., Gabert P., Lancel S., Dekiouk S., Fontaine D., Tardivel M., Savina A., Quesnel B., Mortier L., Marchetti P. and Kluza J. (20180111). Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors. : Oncotarget.

MLA

Corazao-Rozas Paola, Guerreschi Pierre, André Fanny, Gabert Pierre-Elliott, Lancel Steve, Dekiouk Salim, Fontaine Delphine, Tardivel Meryem, Savina Ariel, Quesnel Bruno, Mortier Laurent, Marchetti Philippe and Kluza Jérome. Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors. : Oncotarget. 20180111.